Cellis
KRSCompany age:
Age:
10 y. 12 d.
Share capital:
Share capital:
5 000 PLN
| Rating | |||
| Main industry | Research and experimental development on biotechnology | ||
| Account number |
PL03 1240 6074 1111 0011 4681 4603
PL23 1240 6074 1111 0011 4681 4049
PL70 1240 6074 1111 0011 4681 4270
PL70 1240 6074 1111 0011 4681 5046 PL13 1240 6074 1111 0011 1076 6992 PL26 1240 6074 1797 0011 1076 6602 PL32 1240 6292 1978 0011 1811 7965 PL53 1240 6074 1111 0011 1017 4960 PL65 1240 6074 1978 0011 0791 0773 PL79 1240 6074 1111 0011 0472 1637 PL79 1240 6074 1787 0011 0800 3782 PL65 1240 6074 1111 0011 0472 1695 PL80 1240 6074 1111 0011 4962 9806 |
CELLIS was established on 2015-12-18 and is currently located at UL. GEN. JÓZEFA ZAJĄCZKA 26, PL-01-510, WARSZAWA. The main activity of the company is scientific research and development. Other activities carried out by the company include research and experimental development on biotechnology, manufacture of basic pharmaceutical products, manufacture of pharmaceutical preparations, wholesale of pharmaceutical and medical goods, business and other management consultancy activities and others. As per the latest entry in the National Court Register, the current management board of the company comprises 2 individual(s). The most recent update in the National Court Register was recorded on 2025-07-01.